A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 95
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ATBC
Long Form : Alpha-Tocopherol, Beta-Carotene Cancer Prevention
No. Year Title Co-occurring Abbreviation
2020 Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials. CEHC, VEAPS
2019 beta-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine. CI, HR
2019 Coffee and tea drinking and risk of cancer of the urinary tract in male smokers. CIs, HRs
2019 Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival. GC-MS, HR, LC-MS
2019 Prospective serum metabolomic profiling of lethal prostate cancer. BHBA, FDR, OR, s.d
2019 Serum Retinol and Risk of Overall and Site-Specific Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. ---
2018 Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort. CVD, HR
2017 A prospective study of serum metabolites and glioma risk. ---
2017 Effects of beta-Carotene and Its Cleavage Products in Primary Pneumocyte Type II Cells. CARET, CPs, DMNQ
10  2017 Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer. CI, NCGA, UGI
11  2017 Metabolomic Profiling of Serum Retinol in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. SE
12  2017 Serum gastrin and cholecystokinin are associated with subsequent development of gastric cancer in a prospective cohort of Finnish smokers. CCK, GNCA, OR
13  2017 Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. CI, TMAO
14  2017 Validity of a Cochrane Systematic Review and meta-analysis for determining the safety of vitamin E. ---
15  2016 Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival. CI, HR
16  2016 Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. CMPF, DHA, EPA, GPPE, SD
17  2016 Serum Metabolomic Response to Long-Term Supplementation with all-rac-alpha-Tocopheryl Acetate in a Randomized Controlled Trial. ATA
18  2016 Vitamin E and the risk of pneumonia: using the I 2 statistic to quantify heterogeneity within a controlled trial. ---
19  2015 LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk. CIs, ORs, PLCO, RCC
20  2015 Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study. ---
21  2015 PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. NAFLD, PNPLA3
22  2014 Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. CI, OR
23  2014 LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. CIs, ORs, PLCO, PLCO
24  2014 Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers. AMACR, CI, OR
25  2014 Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts. CI, PLCO, SWHS
26  2014 Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma. CIs, DBP, ORs
27  2013 A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study. OR
28  2013 Alcohol consumption, one-carbon metabolites, liver cancer and liver disease mortality. CIs, HR
29  2013 Metabolomic profile of response to supplementation with beta-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. ---
30  2013 Seropositivity to Helicobacter pylori and risk of pancreatic cancer. CI, H. pylori, OR
31  2013 Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis. ALS, RR
32  2012 Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer. CI, OR, TBG, TSH
33  2012 Helicobacter pylori seropositivity and risk of lung cancer. CagA, H. pylori, ORs
34  2012 Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. CI, DBP, OR
35  2012 Pre-diagnostic circulating vitamin D and risk of melanoma in men. ORs
36  2012 Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. OSCC
37  2011 A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. ---
38  2011 Genome-wide association study of circulating retinol levels. InCHIANTI, PLCO, RBP4, TTR
39  2011 Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. mtDNA
40  2011 Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. CRP, PLCO
41  2011 Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not -A or -C, in male smokers. VEGF
42  2010 Atrophic gastritis and the risk of incident colorectal cancer. CRC, HR, S-PGI
43  2010 Dietary acrylamide intake and the risk of cancer among Finnish male smokers. CI, RR
44  2010 Insulin-like growth factors and risk of kidney cancer in men. IGF-I, IGFBP-3
45  2010 No association between fruit, vegetables, antioxidant nutrients and risk of renal cell carcinoma. CI, RCC, RR
46  2009 Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. OR
47  2009 Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. BCMO1
48  2009 Glycaemic index database for the epidemiological Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. GI, GL
49  2009 Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C. ---
50  2009 Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. HDL, RR
51  2009 Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study. CI, HR, S-PGI
52  2009 Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. HRs
53  2008 Analysis of Smoking Cessation Patterns Using a Stochastic Mixed-Effects Model With a Latent Cured State. ---
54  2008 Effect of alpha-tocopherol and beta-carotene supplementation on the incidence of type 2 diabetes. RR
55  2008 Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. RR
56  2008 Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C. RR
57  2008 Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake. RR
58  2007 Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial. CI, RR
59  2006 Beta-carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes. CARET, CAs, CPs, MN, SCE
60  2006 Cancer incidence in a cohort of Finnish male smokers. CI, FCR, SIR
61  2006 Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. RR
62  2006 Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. CIs, CRC, HOMA-IR, HRs, IR
63  2006 Physical activity and the risk of pneumonia in male smokers administered vitamin E and beta-carotene. ---
64  2006 Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). SNPs
65  2006 The effect of vitamin E on common cold incidence is modified by age, smoking and residential neighborhood. ---
66  2006 Validation of a model of lung cancer risk prediction among smokers. CI
67  2005 Cyto- and genotoxic potential of beta-carotene and cleavage products under oxidative stress. CA, CARET, CP, MN, SCE
68  2005 Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland). CI, NAE, RR
69  2005 Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. CIs
70  2004 Cytotoxic and genotoxic effects of beta-carotene breakdown products on primary rat hepatocytes. CARET, CP, SCE
71  2004 Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. CHD, MCE, MI
72  2004 Flavonol and flavone intake and the risk of intermittent claudication in male smokers. ---
73  2004 Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers. CI, RR
74  2003 Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. CI, RR
75  2003 Physical activity and the common cold in men administered vitamin E and beta-carotene. ---
76  2002 A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). CI, HDL, HR
77  2002 Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). CI, RR
78  2002 Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. VEGF
79  2002 Physical activity and lung cancer risk in male smokers. CI, RR
80  2002 The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. FCR
81  2001 Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial. AAA, CI, RR
82  2001 Educational differences in lung cancer mortality in male smokers. RR
83  2001 Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. ---
84  2001 Flavonol and flavone intake and the risk of cancer in male smokers (Finland). ---
85  2000 Beta-carotene: the controversy continues. CARET, PHS
86  2000 Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) CI, RR
87  2000 Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). CI
88  2000 Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. RR
89  2000 Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma. s-CD44
90  1999 Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. ---
91  1999 Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. ---
92  1999 The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations. ---
93  1999 The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. AT, BC
94  1996 Evaluation of human trial findings. ---
95  1996 Serum high density lipoprotein cholesterol, alcohol, and coronary mortality in male smokers. ---